Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65

Launched by MICHAEL MORONT · Mar 31, 2025

Keywords

ClinConnect Summary

The Mosaic Mitral Valve trial is studying how well the Mosaic bioprosthetic heart valve works for people under 65 years old who have had valve replacement surgery at ProMedica Toledo Hospital. This research is important because, while we know a lot about how these valves perform in older patients, there isn't much information about their long-term success in younger patients. The trial aims to assess how effective and stable these valves are after surgery and to understand the overall outcomes for these patients.

To participate in the trial, individuals must be under 65 years old and have received the Mosaic Mitral Valve at ProMedica Toledo Hospital. Unfortunately, those over 65 or under 18, as well as patients who had their surgery at other hospitals, cannot take part. Participants can expect to be monitored for their valve's performance and general health after surgery, which will help doctors learn more about how this type of valve works for younger patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Received the Mosaic Mitral Valve Bioprosthetic at ProMedica Toledo Hospital
• • Under the age of 65
• Exclusion Criteria:
• • Over the age of 65
• • Under the age of 18
• • Surgery performed at institutions outside of ProMedica Toledo Hospital